abagovomab 10
abciximab 20
actoxumab 4
adalimumab 7
alacizumab_pegol 0
alemtuzumab 12
alirocumab 6
amatuximab 8
andecaliximab 9
anrukinzumab 10
aprutumab 6
arcitumomab 4
ascrinvacumab 0
atezolizumab 4
atinumab 11
avelumab 3
basiliximab 6
bavituximab 6
benralizumab 15
bevacizumab_beta 7
bezlotoxumab 4
bimagrumab 3
blinatumomab 14
blosozumab 10
brazikumab 9
brentuximab_vedotin 8
briakinumab 9
brodalumab 4
brolucizumab 11
burosumab 8
camrelizumab 3
canakinumab 8
cantuzumab_ravtansin 17
carlumab 8
carotuximab 3
certolizumab_pegol 13
cetiximab 18
citatuzumab_bogatox 18
cixutumumab 12
conatumumab 10
concizumab 11
crenezumab 10
crizanlizumab 10
crotedumab 10
dacetuzumab 11
daclizumab 6
dalotuzumab 10
daratumumab 7
demcizumab 10
denosumab 3
depatuxizumab 8
dezamizumab 6
dinutuximab 10
drozitumab 6
dusigitumab 11
efalizumab 20
efungumab 6
elezanumab 3
elotuzumab 9
emapalumab 11
enavatuzumab 11
enokizumab 10
enoticumab 8
ensituximab 10
eptinezumab 0
erenumab 4
etaracizumab 10
etrolizumab 18
evolocumab 3
farletuzumab 0
fasinumab 9
fezakinumab 10
fibatuzumab 3
ficlatuzumab 19
flanvotumab 12
foralumab 7
foravirumab 10
fremanezumab 17
fresolimumab 9
fulranumab 11
futuximab 3
ganitumab 11
gantenerumab 6
gemetuzumab 12
gemtuzumab2 9
gemtuzumab 8
gevokizumab 14
girentuximab 11
ibalizumab 16
ibritumomab 0
icrucumab 6
idarucizumab 17
ifabotuzumab 3
imgatuzumab 14
inclacumab 8
indusatumab 9
inebilizumab 8
intetumumab 4
iodine_girentuximab 9
ipilimumab 4
iratumumab 0
isatuximab 10
itolizumab 0
ixekizumab 14
labetuzumab_govitecan 16
lambrolizumab 9
lampalizumab 15
lanadelumab 13
laprituximab 6
lebrikizumab 15
lendalizumab 15
ligelizumab 9
lirilumab 10
lodelcizumab 13
lorvotuzumab_mertansin 3
lucatumumab 3
lupartumab 6
lutikizumab 9
milatuzumab 9
mogamulizumab 12
motavizumab 19
moxetumomab_pasudotox 11
namilumab 13
naratuximab 7
naratuximab_emtansin 7
navicixizumab 10
necitumumab 3
nesvacumab 0
nivolumab 8
obiltoxaximab 4
obinutuzumab 18
ocaratuzumab 9
ofatumumab 10
olaratumab 4
olokizumab 13
omalizumab 13
onartuzumab 11
orticumab 0
otelixizumab 9
oxelumab 3
ozanezumab 12
panobacumab 17
parsatuzumab 15
pasotuxizumab 7
pateclizumab 8
patritumab 5
pembrolizumab 9
perakizumab 6
pidilizumab 5
pinatuzumab_vedotin 6
pogalizumab 17
polatuzumab_vedotin 14
ponezumab 13
prezalumab 14
pritoxaximab 13
quilizumab 4
racotumomab 12
radretumab 0
ramucirumab 5
ranevetmab 13
ranibizumab 9
rilotumumab 10
rituximab 4
robatumumab 10
roledumab 8
romosozumab 8
rontalizumab 15
rosmantuzumab 3
rozanolixizumab 10
samalizumab 15
sapelizumab 8
sarilumab 0
secukinumab 7
seribantumab 4
setoxaximab 17
sifalimumab 6
siltuximab 7
simtuzumab 11
sirukumab 6
solanezumab 15
solitomab 13
stamulumab 4
suptavumab 13
suvizumab 11
tabalumab 4
tadocizumab 3
tamtuvetmab 8
tanezumab 17
tavolixizumab 0
telisotuzumab 13
teplizumab 9
tigatuzumab 9
tildrakizumab 14
tositumomab 0
tralokinumab 18
trastuzumab 13
tregalizumab 8
ublituximab 6
urelumab 6
ustekinumab 16
utomilumab 3
vatelizumab 7
vedolizumab 6
veltuzumab 3
vesencumab 6
vunakizumab 14
zatuximab 13
